Platelet Rich Plasma Market Analysis Report By Type, By Application, By End-use, By Region And Segment Forecasts From 2021 To 2028

Synopsis

The global platelet rich plasma market was expected by USD 476.1 million in 2020. It is likely to observe 12.0% CAGR from 2021 to 2028.

Drivers

Platelet rich plasma (PRP) is established to be the important basis of autologous products in the subject of regenerative medicine, in addition to a correct forerunner for the curative procedure together with stem cells and scaffold. An enlargement in the occurrences of orthopedic illness and sports injuries are placed to boost the demand for PRP treatment. The increasing research support is likely to increase the demand for platelet rich plasma grounding products.

Whilst used in alliance with additional materials, it has, moreover, revealed enhanced results in periodontal treatment. Additionally, the hopeful outcomes have turned up while these products are utilized only like a covering material in implant surgical treatments.

The amalgamation of platelet rich plasma, together with necrotic bone curettage has revealed hopeful consequences in the curing of refractory bisphosphonate-related osteonecrosis of the jaw, as this mixture gives lucrative results, by way of minimally invasive surgical treatments.

Application Insight

The orthopedics section held the principal, 29.8% revenue share and led the platelet rich plasma (PRP) market, in 2020. Consistent with a variety of research reviews, it is discovered to be largely effectual in the medication of chronic ligament injuries, wherein they contain the prospective to speed up the curative procedure.

The dermatology section is likely to develop by a major, 13.5% CAGR during the forecast period. The utilization of autologous PRP has confirmed to be the proficient therapy for diabetic ulcers along with additional non-healing ulcers. Besides, platelet rich plasma sourced treatment methods are more prepared to increase vast toehold, credited to price efficiency, easiness of use, and assisting enlargement factors, to improve tissue remedial. This has augmented the acceptance of PRP through a variety of research actions, accepted on the method of ulcer curing, adding to the enlargement of the section.

Type Insight

The pure platelet rich plasma division held the major, 52.8% revenue share and led the market in 2020. Several advantages connected with pure PRP for example, tissue generation and repair, speeding up the healing procedure, along with the enhancement in general function, have augmented their demand through diverse places of therapeutics industry, which is additionally contributing to expansion of the division.

In contrast, leukocyte rich platelet rich plasma is likely to develop by a fast speed with 12.5% CAGR, during the forecast period. In spite of the possible threats related with leukocyte rich PRP, this market is observing a considerable enhancement in the business group, plus the number of investigational arrangement and increasing possible functions through sports medicine, orthopedic, and general surgical procedure. These factors are expected to push leukocyte rich PRP by the highest speed, during the forecast period.

End Use Insight

The hospitals division held the major, above 49.0% revenue share and led the platelet rich plasma market, in 2020, because there is a considerable amount of hospitals, globally, presenting PRP sourced treatments. In middle-income nations, the hospitals are highly concentrating on PRP action, used for the esthetic functions. The hospitals are expected to create extra revenue during the near future, by means of the rising acceptance of PRP therapy.

The clinical division is pushed by increasing medical tourism in the nations like Costa Rica, Mexico, and China.

Regional Insight

In 2020, North America held the major, 45.5% revenue share and led the global platelet rich plasma market. This can be credited to increasing figure of cosmetics surgical treatments, augmented alertness regarding the PRP treatments, and the technical progressions, within the region.

The dynamic participation of research and academic institutes like Springfield College of Health Care, Management and Technology, and Yale School of Medicine, intended for assessing the functions of platelet-rich plasma treatments, additionally increase speed of the market expansion, with in the region.

Besides, in North America, the existence of encouraging regulatory establishments is more propelling the enlargement of the market. The U.S. FDA’s Center for Biologics Evaluation and Research is the authoritarian organization, accountable for the platelet rich plasma products. It grants 510(k) treatment authorization for the promotion of platelet rich plasma preparation arrangement in the U.S. Therefore, a robust research as well as commercial support for the platelet rich plasma treatments is adding to the enlargement of the market, within the region.

Asia Pacific is projected to observe the maximum 14.1% CAGR, during the forecast period. The increasing figure of the cosmetic surgical treatments to enhance the facial features in the nations like Thailand, Korea, and India is expected to increase the development of the market, within the region. Besides, the rising medical tourism business, within the region, is anticipated to increase the acceptance of platelet rich plasma treatments, in this market.

The operational involvement of research and academic establishments, like the University of Tsukuba and Guangzhou University of Chinese Medicine, intended for appraise the use of platelet rich plasma therapies is, furthermore, increasing the market within the region.

Companies

Increasing functions of platelet rich plasma (PRP) treatment have created lucrative openings for the companies, busy in developing procedure of platelet rich plasma (PRP) treatment services, along with the solutions, intended for the wound care sections comprising ulcer curing. The market participants are keenly in the process of planned acquisitions, to make stronger their presence in the market.

Some of the companies for platelet rich plasma market are:

• APEX Biologix
• Dr. PRP America
• Terumo BCT, Inc.
• Stryker
• Johnson & Johnson (DePuy Synthes)
• Celling BioSciences
• Juventix
• Arthrex, Inc.
• EmCyte Corporation
• Zimmer Biomet

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2028. For the purpose of this study, Million Insights has segmented the global platelet rich plasma market report on the basis of type, application, end-use, and region:

• Type Outlook (Revenue, USD Million, 2017 - 2028)
    • Pure Platelet Rich Plasma
    • Leukocyte Rich Platelet Rich Plasma
    • Others

• Application Outlook (Revenue, USD Million, 2017 - 2028)
    • Orthopedics
    • Sports Medicine
    • Cosmetic Surgery
    • Dermatology
        • Ulcer Healing
            • Venous Ulcer
            • Traumatic Ulcer
            • Diabetic Ulcer
            • Pyoderma Gangrenosum Ulcer
            • Trophic Ulcer
            • Vasculitic Ulcer
            • Others
        • Others
    • Ophthalmic Surgery
    • Neurosurgery
    • General Surgery
    • Others

• End-use Outlook (Revenue, USD Million, 2017 - 2028)
    • Hospitals
    • Clinics
    • Others

• Regional Outlook (Revenue, USD Million, 2017 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
       • Germany
       • U.K.
    • Asia Pacific
       • China
       • Japan
    • Latin America
       • Brazil
       • Mexico
    • Middle East and Africa (MEA)
       • South Africa